Clinical Trial Update: Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy [Phase 1]

View source ↗

Summary

This Phase 1 study reports on the safety and tolerability of VGR-R01 in patients with Bietti Crystalline Dystrophy. The trial is currently active and not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bietti Crystalline Dystrophy

Drugs mentioned

• VGR-R01

Snippet

Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. | Conditions: Bietti Crystalline Dystrophy | Phase 1 | Status: ACTIVE_NOT_RECRUITING